27 August 2021 (Friday) - ASH Update

The nice people at the American Society of Hematology focussed on haemostasis in today’s update. Perhaps a tad over my head? But then that’s why I need to do CPD…

Here are the highlights in clotting disorders:

Does Khorana Score Accurately Predict VTE in Patients With Uterine and Ovarian Cancer? At the 2021 ASCO Annual Meeting, researchers shared results from two studies examining the Khorana score for predicting VTE in patients with gynecologic cancers.

Dabigatran Etexilate Approved for Children with VTE The FDA has approved the first oral anticoagulant for the treatment of children with venous thromboembolism who have received injectable anticoagulants for at least five days, or as prophylaxis for recurrent thrombosis.

Comparing VTE Recurrence, Bleeding, and Death in Isolated Distal Versus Proximal DVT Patients with isolated distal DVT and proximal DVT have similar long-term rates of VTE recurrence, bleeding, and death, according to an analysis of real-world data published in the Journal of Thrombosis and Haemostasis.